Filter Results:
(5,808)
Show Results For
- All HBS Web
(5,808)
- People (11)
- News (902)
- Research (4,158)
- Events (26)
- Multimedia (55)
- Faculty Publications (2,835)
Show Results For
- All HBS Web
(5,808)
- People (11)
- News (902)
- Research (4,158)
- Events (26)
- Multimedia (55)
- Faculty Publications (2,835)
- 2024
- Working Paper
Finance Without Exotic Risk
By: Pedro Bordalo, Nicola Gennaioli, Rafael La Porta and Andrei Shleifer
We address the joint hypothesis problem in cross-sectional asset pricing by using measured analyst expectations of earnings growth. We construct a firm-level measure of Expectations Based Returns (EBRs) that uses analyst forecast errors and revisions and shuts down any... View Details
Bordalo, Pedro, Nicola Gennaioli, Rafael La Porta, and Andrei Shleifer. "Finance Without Exotic Risk." NBER Working Paper Series, No. 33004, September 2024.
- 2006
- Dissertation
Enterprise Risk Management in Action
By: Anette Mikes
The new Basel regulatory initiatives and a burgeoning risk management literature signify the rise of enterprise risk management (ERM) in the financial services sector. However, very little is known of the roles that risk management plays in organizations and how it... View Details
- fall 2002
- Article
Distortion and Risk in Optimal Incentive Contracts
By: George P. Baker
Baker, George P. "Distortion and Risk in Optimal Incentive Contracts." Journal of Human Resources 37, no. 4 (fall 2002).
- September 2002 (Revised August 2003)
- Case
Genzyme's Gaucher Initiative: Global Risk and Responsibility
By: Christopher A. Bartlett and Andrew N. McLean
In Egypt, Genzyme's humanitarian commitment to treat all sufferers of the rare Gaucher disease worldwide first confronts its commercial imperative to recoup the huge investment required to bring the drug Cerezyme to market. Here Tomye Tierney must decide how to balance... View Details
Keywords: Moral Sensibility; Investment; Emerging Markets; Negotiation; Corporate Social Responsibility and Impact; Business and Government Relations; Sales; Commercialization; Expansion; Value Creation
Bartlett, Christopher A., and Andrew N. McLean. "Genzyme's Gaucher Initiative: Global Risk and Responsibility." Harvard Business School Case 303-048, September 2002. (Revised August 2003.)
- 02 Sep 2009
- Working Paper Summaries
Information Risk and Fair Value: An Examination of Equity Betas and Bid-Ask Spreads
- Research Summary
Contract Rights and Risk Aversion: Foreign Banks and the Mexican Economy, 1997-2004
In 1997 Mexicos banking laws were reformed, allowing foreign banks, for the first time since the nineteenth century, to purchase controlling interests in the countrys largest banks. Foreign banks controlled 16 percent of Mexican bank assets in March 1997. By June... View Details
- 01 Apr 2001
- News
Jimmy Lai Chee-ying: Rags, Riches, and Risk
“In the media business, it’s important to make sure your content is fresh,” says Jimmy Lai Chee-ying, chairman of Next Media, Ltd. The Hong Kong entrepreneur is doing just that, as he keeps taking risks and... View Details
- Teaching Interest
Risk Management for Corporate Leaders
By: Robert Simons
As companies adapt to the aftershocks of the global recession, senior executives and boards are discovering that risk management has never been more important. The financial crisis revealed that risk management structures break down just when... View Details
- 2007
- Book
Perspectives on Risk and Regulation: The FDA at 100
By: Arthur A. Daemmrich and Joanna Radin
Perspectives on Risk and Regulation: The FDA at 100 brings together the viewpoints of Food and Drug Administration officials and industry leaders on the future of regulating food, drugs, medical devices, and dietary supplements. In a period of rapid scientific... View Details
Keywords: Private Sector; Governing Rules, Regulations, and Reforms; Policy; Health Care and Treatment; Business and Government Relations; Risk and Uncertainty; Cooperation
Daemmrich, Arthur A., and Joanna Radin, eds. Perspectives on Risk and Regulation: The FDA at 100. Chemical Heritage Foundation, 2007. (Fulltext.)
- March 2006 (Revised August 2006)
- Supplement
Kevin McCarthy and Westlake Chemical Corporation (B): More Uncertainty on the Horizon
Riedl, Edward J. "Kevin McCarthy and Westlake Chemical Corporation (B): More Uncertainty on the Horizon." Harvard Business School Supplement 106-064, March 2006. (Revised August 2006.)
- November 2012 (Revised January 2014)
- Case
The LEGO Group: Envisioning Risks in Asia (A)
By: Anette Mikes and Dominique Hamel
On January 1, 2012, the LEGO Group announced a major new initiative to enhance its market penetration in Asia. Later in the year, a cross-functional group of senior managers gathered at company headquarters to discuss the status of the Asian initiative and the risks... View Details
Keywords: LEGO; Toy Industry; Fashion And Creative Industries; Organizational Structure; Risk Management; Supply Chain Management; Organizational Design; Entertainment and Recreation Industry; Denmark; Asia
Mikes, Anette, and Dominique Hamel. "The LEGO Group: Envisioning Risks in Asia (A)." Harvard Business School Case 113-054, November 2012. (Revised January 2014.)
- January 2005
- Article
Agency Costs in a Supply Chain with Demand Uncertainty and Price Competition
By: V.G. Narayanan, Ananth Raman and J. Singh
Narayanan, V.G., Ananth Raman, and J. Singh. "Agency Costs in a Supply Chain with Demand Uncertainty and Price Competition." Management Science 51, no. 1 (January 2005).
- 01 Nov 2020
- News
The Risks You Can’t Foresee
- 02 Apr 2020
- Working Paper Summaries
Strategic Foresight as Dynamic Capability: A New Lens on Knightian Uncertainty
Keywords: by J. Peter Scoblic
- May–June 2018
- Article
Data Uncertainty in Markov Chains: Application to Cost-Effectiveness Analyses of Medical Innovations
By: Joel Goh, Mohsen Bayati, Stefanos A. Zenios, Sundeep Singh and David Moore
Cost-effectiveness studies of medical innovations often suffer from data inadequacy. When Markov chains are used as a modeling framework for such studies, this data inadequacy can manifest itself as imprecision in the elements of the transition matrix. In this paper,... View Details
Keywords: Markov Chains; Cost Effectiveness; Medical Innovations; Colorectal Cancer; Health Care and Treatment; Cost vs Benefits; Innovation and Invention; Mathematical Methods; Health Industry
Goh, Joel, Mohsen Bayati, Stefanos A. Zenios, Sundeep Singh, and David Moore. "Data Uncertainty in Markov Chains: Application to Cost-Effectiveness Analyses of Medical Innovations." Operations Research 66, no. 3 (May–June 2018): 697–715. (Winner, 2014 INFORMS Health Applications Society Pierskalla Award & Finalist, 2014 INFORMS George E. Nicholson student paper competition.)
- 2013
- Case
Travelers Insurance: Focusing on Climate Change and Natural Catastrophe Risk
By: Andrew J. Hoffman
The dilemma Evan Blue faces stems from a report by sustainability advocacy group Ceres that calls on companies to take climate change into consideration in their risk models and develop response strategies. The fictional vice president of Traveler's Insurance is tasked... View Details
Hoffman, Andrew J. "Travelers Insurance: Focusing on Climate Change and Natural Catastrophe Risk." William Davidson Institute Case 1-429-347, 2013.
- Research Summary
Time-Varying Volatility Risk Premia
This paper provides evidence for the existence of time-varying volatility risk premia. In doing so, it examines the evolution of the implied volatility bias in the S&P 100 from 1986-2006. Additionally, the paper proves three new results regarding the limiting... View Details
- 09 Jun 2009
- Research Event
Business Summit: Enterprise Risk Management
ServicesM.D. Ranganath, Chief Risk Officer, InfosysBarry Zubrow, Chief Risk Officer, JP Morgan Chase The global companies profiled in this session—Infosys, GE Capital Services, View Details
Keywords: Re: Robert S. Kaplan
- Teaching Interest
Risk Management for Corporate Leaders
As companies adapt to the aftershocks of the global recession, risk management is a top priority for their senior executives and boards—and for those of nonprofit and public-sector enterprises as well. The financial crisis revealed that risk management processes cannot... View Details
- June 2024
- Article
Counterparty Risk and Counterparty Choice in the Credit Default Swap Market
By: Wenxin Du, Salil Gadgil, Michael Gordy and Clara Vega
We investigate how market participants price and manage counterparty credit risk using confidential trade repository data on single-name credit default swap (CDS) transactions. We find that counterparty risk has a modest impact on the pricing of CDS contracts but a... View Details
Keywords: Credit Derivatives and Swaps; Market Participation; Risk and Uncertainty; Price; Financial Markets; Credit
Du, Wenxin, Salil Gadgil, Michael Gordy, and Clara Vega. "Counterparty Risk and Counterparty Choice in the Credit Default Swap Market." Management Science 70, no. 6 (June 2024): 3808–3826.